Thermo Fisher to Offer Senior Notes | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today filed a registration statement with the US Securities and Exchange Commission to offer senior notes to fund its acquisition of Dionex, as well as for general corporate purposes.

Details of the offering have yet to be determined, including the total amount Thermo Fisher is seeking to raise, other than the firm's intention offer three sets of senior notes due 2014, 2016, and 2021, respectively.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.